Delivery Order SPE2DB20D2104-SPE2DB25FMWMM
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,858.72. This competitive award, issued without a set-aside designation, carries a firm fixed price structure with an ultimate completion date of July 24, 2025. The product will be performed and distributed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,500.88 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price delivery order is a non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens in 0.5 ml quantities, with a ceiling value of $2,619.55. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $2,344.84. This firm fixed-price delivery order, which must be completed by July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is unclassified as a set-aside contract, indicating it was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,302.84 for Trulicity 1.5 mg/0.5 ml pens by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price contract is not set-aside and represents a single delivery of the diabetes medication to support military healthcare operations. The award is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,228.06 by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which is not set-aside and carries an ultimate completion date of July 24, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $5,756.58 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract is a non-set-aside competitive award and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a $3,648.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price contract, which is part of a larger Indefinite Delivery Contract vehicle, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The...
- The Defense Logistics Agency awarded a $7,269.12 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract, which was not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWMMDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order on July 25, 2025, by the Defense Logistics Agency for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,272.09. The contract employs firm fixed pricing and is not set-aside, indicating it was awarded through open competition. Performance will be completed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor supporting federal military and veteran healthcare systems through the DLA Medical Supply Chain. The company's comprehensive IDC vehicle enables supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This particular delivery order for Trulicity, a diabetes medication, reflects the contractor's ongoing role in fulfilling pharmaceutical procurement requirements for the Defense Health Agency and other federal healthcare entities. The DLA is planning to establish successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the key vendors supporting this strategic transition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/25/25 |